Prof Gilbert G G Donders, MD, PhD is an expert in Gynecology at Antwerp University Hospital (Belgium). As of November 2026, ScienceLeadR ranks Gilbert G G Donders in the top 1% of experts worldwide for Vaginal Diseases and Vaginitis, and in the top 1% of experts in Belgium for Vulvar Diseases. Gilbert G G Donders has authored 252 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 3 of them ongoing. SLR score: 842 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Gilbert G G Donders, MD, PhD Antwerp University Hospital Belgium
842 ScienceLeadR Reputation 842
Network Map

Gynecology

Subspecialties: Public Health - Oncology - Infectiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1989 - 2026
Source: PubMed

Antwerp University Hospital - Gynecologist

2012 - 2026

University of Antwerp - Professor

2013 - 2026

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 252

Citations

Citations: 10 039 1st author: 96 Last author: 40 Unique author: 15


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Local albumin excess exacerbates Candida albicans-induced inflammasome activation linked with hyperinflammation during vulvovaginal candidiasis.
PMID 42957760 — candidiasis, macrophages, inflammasomes, candida albicans, candidiasis, vulvovaginal, mucous membrane, candida, vagina
Nat Commun20260
Citizen science reveals comorbidities in endometriosis with no shift in vaginal microbiome composition.
PMID 42712474 — endometriosis, comorbidity, ovary, citizen science
NPJ Womens Health20260
Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program.
PMID 42537360 — research design, safety, sleep, signs and symptoms, therapeutics, menopause, geriatrics
Maturitas20260
Accuracy of Allplex HPV HR Detection Full Genotyping Assay on Cervical Samples Compared to Vaginal Self-Samples.
PMID 42272135 — neoplasms
J Med Virol20260
Clinical performance of ASCL1/LHX8 DNA methylation on first-void urine to screen for cervical cancer.
PMID 41820501 — research design, uterine cervical neoplasms, triage, neoplasms, dna methylation, alphapapillomavirus, dna, human papillomavirus viruses
Commun Med (Lond)20260

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 4
Phase 3 2
Phase 1/Phase 2 1
Phase 2 1

By status:

Active not recruiting 4
Completed 4

By type:

Interventional 5
Observational 3

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 2
multicentric5to9 3
multicentricup10 3

Main Topics

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
DeVEnIR Defining Vulvovaginal Candidiasis Elements of Infection and Remedy
NCT06397248 — mycology, candidiasis, immunity, candidiasis, vulvovaginal, research, therapeutics, immunity, innate, communicable diseases, infections, women
N/AActive not recruiting2024
Assessing the Safety Immune Response and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis A Randomized Controlled Study
NCT06190509 — candidiasis, safety, vaccines, immunity, candidiasis, vulvovaginal, candida, women
Phase 1/Phase 2Active not recruiting2023
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti cancer Therapy in Women With or at High Risk for Developing Hormone receptor Positive Breast Cancer
NCT05587296 — cells, quality of life, estrogens, safety, breast neoplasms, uterus, neoplasms, hormones, signs and symptoms, drug-related side effects and adverse reactions, hot flashes, breast, records, therapeutics, progesterone, women
Phase 3Active not recruiting2022

LeadR Networks

Main global connection map